Stay updated on Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.

Latest updates to the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s displayed software/version revision was updated from **v3.5.2** to **v3.5.3**, without changing the underlying study information presented on the record.SummaryDifference0.1%

- Check25 days agoChange DetectedWebsite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check61 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.4.2 has been added, and a funding-status notice was removed; these are minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check96 days agoChange DetectedA government funding status notice was added. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.